News

Key Messages for MDG Summit

16 Sep 2010
by Working Group
Action Events
advocacy MDGs stop tb

Dear Partners and Friends,

Stop TB Partnership
Stop TB Partnership

The United Nations High-level Plenary Meeting on the Millennium Development Goals (MDG Summit) will take place next week, from 20-22 September, in New York. This is an important moment to make the case for increased and continued commitments in the fight against TB.

We have prepared a one-page document with key messages on why fighting TB is critical to achieving the MDGs overall. We encourage you to share it widely and also to deliver its key messages – whether you are traveling to the summit, speaking to media or using the occasion of the summit to seek political commitment in your country.

You can link to the document here (.pdf – 365kb).

Many thanks and warm regards,

On behalf of Dr Giuliano Gargioni, Executive Secretary a.i., Stop TB Partnership

Judith Mandelbaum-Schmid – Senior Communications Adviser
Stop TB Partnership Secretariat
World Health Organization

More News
22 Jul 2024

With NIH Funding, A New Consortium Aims to Improve TB Treatment

The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024

WHO Released Its Updated Bacterial Priority Pathogens List

On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024

Most Robust TB Drug Pipeline in History

For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...